Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Review: update on the management of calciphylaxis.

Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU.

QJM. 2019 Jan 1;112(1):29-34. doi: 10.1093/qjmed/hcy234. Review.

PMID:
30304522
2.

Calciphylaxis.

Nigwekar SU, Thadhani R, Brandenburg VM.

N Engl J Med. 2018 Jul 26;379(4):399-400. doi: 10.1056/NEJMc1807324. No abstract available.

PMID:
30044942
3.

Calciphylaxis.

Nigwekar SU, Thadhani R, Brandenburg VM.

N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292. Review. No abstract available.

PMID:
29719190
4.

Calciphylaxis: Another Piece of the Puzzle.

Brandenburg VM, Sinha S.

Am J Nephrol. 2017;46(5):427-428. doi: 10.1159/000484545. Epub 2017 Nov 9. No abstract available.

5.

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency.

Ketteler M, Brandenburg VM.

J Am Soc Nephrol. 2017 Jun;28(6):1667-1668. doi: 10.1681/ASN.2017020180. Epub 2017 Apr 3. No abstract available.

6.

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.

Rothe H, Brandenburg V, Haun M, Kollerits B, Kronenberg F, Ketteler M, Wanner C.

PLoS One. 2017 Feb 17;12(2):e0172407. doi: 10.1371/journal.pone.0172407. eCollection 2017.

7.

Hypothesis: Phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification.

Joubert P, Ketteler M, Salcedo C, Perello J.

Med Hypotheses. 2016 Sep;94:89-92. doi: 10.1016/j.mehy.2016.07.005. Epub 2016 Jul 12.

PMID:
27515210
8.

Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

Brandenburg VM, Evenepoel P, Floege J, Goldsmith D, Kramann R, Massy Z, Mazzaferro S, Schurgers LJ, Sinha S, Torregrosa V, Ureña-Torres P, Vervloet M, Cozzolino M; ERA-EDTA Working Group on CKD-MBD and EUCALNET.

Nephrol Dial Transplant. 2016 Aug;31(8):1211-9. doi: 10.1093/ndt/gfw025. Epub 2016 Mar 22.

PMID:
27005994
9.

Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.

Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, Schmitz S, Krüger T, Floege J, Ketteler M.

Nephrol Dial Transplant. 2017 Jan 1;32(1):126-132. doi: 10.1093/ndt/gfv438.

PMID:
26908770
10.

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet).

Brandenburg V, Adragao T, van Dam B, Evenepoel P, Frazão JM, Ketteler M, Mazzaferro S, Urena Torres P, Ramos R, Torregrosa JV, Cozzolino M.

Clin Kidney J. 2015 Oct;8(5):567-71. doi: 10.1093/ckj/sfv056. Epub 2015 Jul 6. Review.

11.

Vascular calcification in chronic kidney disease: an update.

Schlieper G, Schurgers L, Brandenburg V, Reutelingsperger C, Floege J.

Nephrol Dial Transplant. 2016 Jan;31(1):31-9. doi: 10.1093/ndt/gfv111. Epub 2015 Apr 26.

PMID:
25916871
12.

Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases.

Ketteler M, Biggar PH.

Clin J Am Soc Nephrol. 2015 May 7;10(5):726-8. doi: 10.2215/CJN.03350315. Epub 2015 Apr 17. No abstract available.

13.

From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.

Brandenburg VM, D'Haese P, Deck A, Mekahli D, Meijers B, Neven E, Evenepoel P.

Pediatr Nephrol. 2016 Feb;31(2):195-206. doi: 10.1007/s00467-015-3069-7. Epub 2015 Mar 4. Review.

PMID:
25735207
14.

[Calciphylaxis].

Brandenburg VM, Martin H, Sohn CM, Ketteler M.

Dtsch Med Wochenschr. 2015 Mar;140(5):347-51. doi: 10.1055/s-0041-100834. Epub 2015 Mar 3. Review. German.

PMID:
25734678
15.

Calcific uremic arteriolopathy: a call for action.

Brandenburg VM, Cozzolino M, Mazzaferro S.

Semin Nephrol. 2014 Nov;34(6):641-7. doi: 10.1016/j.semnephrol.2014.09.007. Review.

PMID:
25498382
16.

Integrated image data and medical record management for rare disease registries. A general framework and its instantiation to theGerman Calciphylaxis Registry.

Deserno TM, Haak D, Brandenburg V, Deserno V, Classen C, Specht P.

J Digit Imaging. 2014 Dec;27(6):702-13. doi: 10.1007/s10278-014-9698-8.

17.

Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Brandenburg VM, Sinha S, Specht P, Ketteler M.

Pediatr Nephrol. 2014 Dec;29(12):2289-98. doi: 10.1007/s00467-013-2746-7. Epub 2014 Jan 29. Review.

PMID:
24474577
18.

Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.

Kramann R, Brandenburg VM, Schurgers LJ, Ketteler M, Westphal S, Leisten I, Bovi M, Jahnen-Dechent W, Knüchel R, Floege J, Schneider RK.

Nephrol Dial Transplant. 2013 Apr;28(4):856-68. doi: 10.1093/ndt/gfs466. Epub 2012 Dec 6.

PMID:
23223222
19.

Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients.

Krüger T, Brandenburg V, Schlieper G, Marx N, Floege J.

Nephrol Dial Transplant. 2013 Mar;28(3):534-41. doi: 10.1093/ndt/gfs485. Epub 2012 Nov 23. Review.

PMID:
23180880
20.

Calcification inhibitors in vascular calciphylaxis associated with normal renal function.

Brandenburg V, Al-Fakhri N, Nemeth K, Goettsch C, Schurgers LJ, Vermeer C, Hofbauer LC, Schoppet M.

Thromb Haemost. 2012 Dec;108(6):1241-3. doi: 10.1160/TH12-07-0484. Epub 2012 Oct 23. No abstract available.

PMID:
23092963

Supplemental Content

Loading ...
Support Center